Also trades as: NOVO-B.CO (CPH) · $vol 179M · NOV.DE (XETRA) · $vol 8M · NOVC.DE (XETRA) · $vol 5M · NONOF (OTC) · $vol 3M · NOVO.TO (TSX) · $vol 0M
NVO NYSE
Novo Nordisk A/S
1W: -3.9%
1M: -20.2%
3M: -24.3%
YTD: -28.8%
1Y: -37.0%
3Y: -58.2%
5Y: -22.3%
$37.32
-0.08 (-0.21%)
Weekly Expected Move ±5.0%
$34
$35
$37
$39
$41
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$542.9B
+16.6% ▲
5Y CAGR: +86.9%
Total Liabilities
$348.9B
+8.2% ▲
5Y CAGR: +91.9%
Shareholders Equity
$194.0B
+35.2% ▲
5Y CAGR: +79.5%
Cash & Investments
$27.0B
+2.5% ▲
5Y CAGR: +66.7%
Total Debt
$131.0B
+27.4% ▲
5Y CAGR: +138.4%
Net Debt
$104.5B
+19.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $10.7B | $12.7B | $14.4B | $15.7B | $26.5B |
| Short-Term Investments | $6.8B | $10.9B | $15.8B | $10.7B | $498M |
| Cash & ST Investments | $17.5B | $23.6B | $30.2B | $26.3B | $27.0B |
| Net Receivables | $46.8B | $57.5B | $75.3B | $87.4B | $75.7B |
| Inventory | $19.6B | $24.4B | $31.8B | $40.8B | $49.6B |
| Other Current Assets | $1.7B | $9.7B | $2.3B | $6.3B | $20.2B |
| Total Current Assets | $85.6B | $108.2B | $139.6B | $160.9B | $172.5B |
| Property, Plant & Equip. | $55.4B | $66.7B | $91.0B | $162.5B | $208.4B |
| Goodwill & Intangibles | $43.2B | $51.4B | $60.4B | $111.1B | $130.1B |
| Long-Term Investments | $1.4B | $1.3B | $1.7B | $2.7B | $2.5B |
| Other Non-Current Assets | $267M | $206M | $1.4B | $4.0B | $29.5B |
| Total Non-Current Assets | $108.9B | $133.1B | $174.8B | $304.9B | $370.4B |
| Total Assets | $194.5B | $241.3B | $314.5B | $465.8B | $542.9B |
| — Liabilities — | |||||
| Accounts Payable | $8.9B | $15.6B | $25.6B | $28.8B | $19.8B |
| Short-Term Debt | $12.9B | $480M | $5.3B | $11.8B | $12.0B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $73.3B | $103.9B | $38.1B | $165.9B | $175.5B |
| Total Current Liabilities | $99.5B | $120.9B | $169.7B | $217.5B | $215.7B |
| Long-Term Debt | $9.7B | $20.8B | $16.0B | $84.2B | $110.4B |
| Other Non-Current Liab. | $6.0B | $5.5B | $7.6B | $9.7B | $7.6B |
| Total Non-Current Liabilities | $24.2B | $36.8B | $38.3B | $104.8B | $133.2B |
| Total Liabilities | $123.8B | $157.8B | $207.9B | $322.3B | $348.9B |
| — Equity — | |||||
| Common Stock | $462M | $456M | $451M | $446M | $446M |
| Retained Earnings | $72.0B | $80.6B | $104.8B | $144.4B | $195.3B |
| Accumulated OCI | -$1.7B | $2.4B | $1.3B | -$1.4B | -$1.7B |
| Total Stockholders Equity | $70.7B | $83.5B | $106.6B | $143.5B | $194.0B |
| Total Liabilities & Equity | $194.5B | $241.3B | $314.5B | $465.8B | $542.9B |
| — Key Metrics — | |||||
| Total Debt | $26.6B | $25.8B | $27.0B | $102.8B | $131.0B |
| Net Debt | $15.9B | $13.1B | $12.6B | $87.1B | $104.5B |
| Total Investments | $8.2B | $12.3B | $17.5B | $13.3B | $3.0B |